Clare Jones

Clare Jones is currently the Chief Scientific Officer at Talisman Therapeutics Limited, as well as the Head of R&D at GEN2 NEUROSCIENCE LTD. With a background in neuroscience and pharmacology, Clare has held various senior positions in research and development in companies such as MedImmune, Xention Discovery, and AstraZeneca. Clare's expertise lies in neuroinflammation, multiple sclerosis, and ion channel target identification within respiratory and inflammation research areas. Clare's research experience ranges from postdoctoral work at CNRS Marseille to completing a PhD in Pharmacology from the University of Cambridge.